Orthobiologics Market by Product Global Analysis & Forecast
2019-2030
Market Industry Reports (MIR) has published a new report titled “Orthobiologics Market - Global
Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report,
the global orthobiologics market was valued at over US$ 5.5 Bn. in 2017 and is expected to grow at
a considerable CAGR during the forecasted period.
The growth of this market can be attributed to the factors such as, increase in sports injuries and
road accidents, awareness among patients & athletes, rise in obesity rate, and continuously aging
population. According to the World Health Organization, 2017, fatal road accidents are the second
primary cause of factures and accidental injury worldwide with almost 646000 individuals die every
year around the world.
Increasing hip and knee replacement surgeries
Osteoarthritis is one of the most disabling diseases majorly in developed countries. Substantial
advances in treatment and surgical methods have provided effective options to decrease the
disability and pain associated with some of the musculoskeletal conditions. Hip and knee joint
replacement surgery is considered as the most effective intervention for severe form of osteoarthritis
and fractures, reducing disability and pain, also restoring some patients to normal function.
According to the data published by the OECD Health Statistics, in 2017, hip replacement rate is
increased by 30% between 2000 and 2015 while the rate of knee replacement doubled.
Browse key industry insights spread across 150 pages with market data tables & figures & charts
from the report, Orthobiologics Market by Product (Viscosupplementation, Allograft, Stem Cell
Therapy, Demineralized Bone Matrix (DBM)), Application (Spinal Fusion, Reconstructive
Surgery, Soft Tissue), End User (Hospitals, ASCs, Academia) End User (Hospital & Clinics,
Ambulatory Care Centers & Orthopedic Clinics) - Global Analysis & Forecast 2019-2030 in
detail along with the table of contents: https://www.marketindustryreports.com/2/orthobiologics-
market
Rising R&D investment to widen the base for growth
Collaborations and rising R&D investments by the prominent biotechnology and medical device
companies are leading to the introduction of advanced orthobiologics which is expected to widen the
base for growth of the orthobiologics. For instance, Bone Biologics Corp., is in development stages
of its orthobiological product bone growth stimulator Nell-1, in collaboration (2015) with the
University of California. This subsequent increase in R&D efforts led to development of a series of
pipeline products that is projected to provide the vertical with profitable growth opportunities in the
future.
Get Your FREE Sample PDF @ https://www.marketindustryreports.com/pdf/2
Key Point Of Table Of Content :
COMPANY PROFILES (Business Overview, Products/Services Offered, Financial
Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst
Corner)*